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Abstract	
            Aim 
OI have not been studied in a Vietnamese population before. The aim of study was to 
systematically collect epidemiological information, investigate clinical features and create 
clinical database of Osteogenesis Imperfecta (OI) patients in Vietnam for future research and 
treatment strategy development  
Methods 
Participants underwent clinical and physical examinations, also medical records were 
reviewed. Genealogical information was collected and family members’ phenotypical 
manifestations recorded. Cases were classified according to the Sillence classification.  
Results 
Totally 146 OI patients from 120 families studied, 46 with OI type I, 46 patients Type III 
and 54 Type IV. All patients had skeletal deformations. 142 history of fractures, 117 blue sclera, 
89 dentinogenesis imperfecta and 26 hearing loss. Total number of fractures was 1932. 34 
patients had intrauterine and 9 perinatal fractures. Surgery was performed in 163 times in 58 
patients, 100 osteosynthesis and 63 osteotomies. Bisphosphonate treatment was used in 37 
patients. 
Discussion 
The number of affected individuals and predominance of severe forms of OI indicate that  
disease is underdiagnosed in Vietnam, especially in cases without family history or with mild OI 
form. Deformities appeared in all patients with different severity and localization, affecting 
mostly lower limbs. OI medical and surgical treatment rates are low and in most cases surgery 
was performed due to fractures. 
Conclusion 
Compared to previous studies, our results indicate a lower OI prevalence and greater 
severity of symptoms in the Vietnamese population comparing to other areas. Further 
investigation, improved diagnosis and treatment is needed to increase patients’ quality of life. 
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Introduction 
Osteogenesis imperfecta (OI) is a group of genetic disorders, also known as “brittle bone 
disease”. OI is characterized by low bone mass, bone fragility and skeletal deformity [1]. Clinical 
severity varies widely, from nearly asymptomatic with a mild predisposition to fractures, normal 
stature and normal lifespan, to profound disability or even fatality [2]. The genetics of this 
disorder are extremely heterogeneous. An estimated 90% of individuals affected by OI are 
heterozygous for the causative variant in one of two genes (COL1A1 or COL1A2) that code the 
main structural protein of bone - collagen Type I [3, 4]. Estimated OI prevalence rate in the 
United States is one case per 10,000 live births, but incidence worldwide varies [5]. Sillence et al. 
reported a prevalence of 3-4/100,000 and an incidence of 3.5/100,000 live births for OI Type I in 
Victoria, Australia [4, 6].  
The major clinical characteristics of OI include bone fragility, osteopenia, varying degrees 
of short stature and progressive skeletal deformities. Additional clinical manifestations are blue 
sclera, Dentinogenesis imperfecta (DI), joint laxity and mature-onset deafness. Mobility, self-care 
and other functional activities are curtailed as a result [1, 3]. The Sillence (1979) Classification of 
OI, which is still in use today, is based on clinical symptoms, type of inheritance and 
radiographic findings [3, 6]; Type I is a mild form of the disorder; Type III is characterized by 
severe deformity and short stature; Type IV varies from mild to severe and represents an 
intermediate stage between Types I and III [2-4, 7]; OI Type II patients usually die in the prenatal 
age [1, 7].  
Information regarding the clinical features and epidemiology of OI in Vietnam is lacking. 
In addition, there is no systematic reports of OI patients in Vietnam. With a population of almost 
90 million, Vietnam is predicted to have a large number of OI patients. We started to 
systematically investigate OI in Vietnam during 2013. The main aim of this study was to describe 
the clinical features of OI patients in Vietnam, systematize the phenotype manifestations of 
affected individuals, collect genealogical information from Vietnamese OI families, describe the 
epidemiology and create an OI database with the aim of improving assessment of and treatment 
quality for OI patients in Vietnam. 
Methods	
Lists of OI patients were collected from hospitals and OI centres from 34 of Vietnam’s 63 
provinces (populations of 60,927,100 and 90,728,900 respectively) [8]. Investigators contacted 
families directly to agree an interview and a clinical examination. The study was conducted in 
accordance with the Helsinki Declaration and received approval from the ethical review board of 
Hue University Hospital (approval No. 75/CN-BVYD). Informed written consent from patients 
or their legal representatives was obtained before they were included in the study. Consent was 
also obtained for the publishing of photographs and or pedigrees in medical journals. A total of 
146 OI patients from 120 OI families agreed to participate in the study. To characterize OI 
patients’ clinical features, all participants underwent clinical and physical examinations and their 
medical records were reviewed. Cases were described according to the Sillence classification 
(Types I–IV).  
All genealogical and clinical information was registered. Interviews with OI families were 
conducted in order to obtain genealogical information for a minimum of three consecutive 
generations. Genealogical information included OI history and family consanguinity data. In 
addition to information regarding the healthy and OI affected members of each family, the history 
of miscarriages and full term pregnancies was obtained. Based on this information a pedigree was 
constructed for each family using satistical program R. Patient and their family clinical 
information, medical history, health problems and treatment associated with OI were recorded 
from patients  medical records or as stated by patient. Each patient was examined for skeletal and 
extraskeletal sings of OI and radiology records, if available, reviewed. Diagnosis and type 
confirmed based on observed clinical features and radiologic findings. Phenotype description was 
based on patient information, i.e. birth data (height, weight, intrauterine and birth fractures), 
fracture history (time and location of the first fracture, total number of fractures and location of 
fractures), skeletal deformations, non-skeletal OI features (hearing loss, presence of DI, sclera 
colour) and degree of physical mobility. Deformities of the skeleton were assessed by 
observation and palpation. Scoliosis, kyphosis and mobility of the spine were assessed in 
different positions, including with the patient bending forward. Hearing was not tested, but 
information regarding hearing problems was collected from patients and their relatives. Weight 
(kg) and height (cm) were measured during examinations. Birth-weight (kg) and height (cm) 
information were obtained from parents or clinical files.  
 Data analysis was performed with the statistical program R [9].  
Results	
 Of the 120 Vietnamese OI families investigated, 30.8%, 44.2% and 25.0% were 
residents of North, Central and South Vietnam respectively. 61 of the OI patients were female 
and 85 male (Total=146). 70.55% of the OI patients were in the age group 0–15 years. The mean  
birthweight for males and females was 2.7kg±0.53 and 2.6kg±0.43 respectively. Low birthweight 
(<2.5kg) was identified in 39 of 146 cases. 46 patients had OI type I, 46 patients Type III and 54 
patients Type IV, according to Sillence’s classification (Table1).  
 All patients also had some non-skeletal OI features. 117 patients had blue sclera, 89 
patients DI and 26 patients suffered from hearing loss. Musculoskeletal deformations were 
present in all patients. Lower limb deformations were found in 121 patients and upper limb 
deformities in 80 patients. Spine deformations were present in 91 patients and chest deformations 
in 74 patients. Most of the patients needed some mobility assistance. Only 58 patients were 
capable of ambulating independently. The frequency of signs and symptoms according to 
different OI types are presented in Table 2. 
142 of the 146 patients studied had suffered fractures, totally 1932 fractures. The four 
individuals who had not suffered fractures were diagnosed with OI based on positive family 
history, typical long bone deformations and extraskeletal manifestations. 125 of the studied 
individuals suffered their first fracture during the first six years of life. 34 OI patients had a 
history of intrauterine fractures. Perinatal fractures had occurred in 9 patients. The first fractured 
bone for 92 of 142 patients was the femur. The femur was also the most common fractured bone 
and was fractured in 132 of the patients (Table 3). Among those with OI Type III and IV, a total 
of 18 patients had suffered more than 30 fractures during their lifespan. Patients with OI  Types I, 
III and IV had mean fracture values of 6.04; 20.76 and 12.94 respectively (Figure 1).  
Out of 146 patients only 37 were treated with bisphosphonates. Previously different 
bisphosphonates were used in treatment of OI, but during last years only i/v zoledronic acid 
treatment protocol is used. Surgical treatment was performed 163 times, including 100 
osteosynthesis and 63 osteotomy surgeries, in 58 patients (Table 3b). Out of 163 surgeries, femur 
were operated 115 and and tibia 41 times. Most of the surgical devices used in Vietnam are self-
designed due to expensiveness of the commercial implants (Figure 2).  
  
 The 146 OI patients were born to 133 mothers. A history of miscarriages was reported 
by 36 of these mothers. Twenty one of the patients were born preterm (less than 37 weeks 
gestation) and 129 of the patients were born to mothers under 35 years old (Table 4). 
Genealogical information revealed that 99 of the families had no known history of OI. Seventeen 
and four families respectively had two or more generation OI histories and pedigree of typical OI 
family is presented in Figure 3. Four families had twins with at least one twin OI affected. 
 
Discussion	
Incidence of OI worldwide varies, but is frequently estimated to be approximately 1 case 
per 100,000 people [5,10]. We do not believe that incidence of OI in Vietnam is 
disproportionately low, therefore our results suggest that OI is significantly underdiagnosed in 
Vietnam, especially in cases where there is no history of OI in the family and or symptoms are 
mild. Low OI incidence may also be explained by several cultural and economic barriers of 
diagnosis and health care system in Vietnam.  
In our study we identified relatively equal numbers of patients with OI Types I (31.51%), 
III (31.51%) and IV (36.98%). Other studies have shown that the prevalence of Type I patients is 
usually higher compared to Types III and IV [5]. Lin et al. reported OI prevalence in Taiwan as 
39.6% Type I, 20.8% Type III and 39.6% Type IV [11]. We were unable to find reports of OI 
Type II patients, as this form is typically lethal in utero. The predominance of severe forms of OI 
in Vietnam suggests underdiagnosis of mild types of OI.  
There has been discussions about OI classifications. The original Sillence clinical OI 
classification was expanded with new OI types. According to a genetic cause of an OI, a new 
classification of OI was proposed in the last years, where every OI type corresponds to a mutated 
gene. About 90% of OI cases arise due to mutations in the COL1A1 and COL1A2 genes. The rest 
of the cases (estimated 10%) are represented by mostly recessive mutations in the genes 
(CRTAP, LEPRE1, PPIB, SERPINH1, FKBP10, PLOD2, SP7, SERPINF1), including the type: 
I-VI [3,4,6].  New classification of OI is type I-VIII, where type I- IV is based on classical 
Sillence classification. Type V is dominantly inherited and represents moderate-to-severe OI 
cases characterised with hypertrophic calluses and interosseous membrane calcification between 
the radius and ulna. Type VI is clinically similar to type IV however is identified by a 
characteristic mineralization defect revealed in bone biopsy. Type VI is extremely rare and mode 
of inheritance is probably recessive, but it has not been identified yet. Type VII is based on 
recessive CRTAP mutations. Clinically white sclerae, small heads and short stature and Coxa 
vara is common. Type VIII is caused by mutations in the LEPRE1 gene and characterized by 
severe growth deficiency and extreme under-mineralization of the skeleton [12]. However, so far 
we can not use the new genetic classification in our study, as we do not have data on genetic 
causes of all OI cases from the sample. In the future availability of the sequencing technologies 
might decrease the need of phenotyping in diagnosis, but to assess severity and classification, the 
phenotyping still remains important in combination with genetic evaluation and in clinical 
practice the phenotype classification is still essential [13]. 
 There were a total of 61 females (41.78%) and 85 males (58.22%) with OI, resulting in a 
female to male with a ratio 1:1.39. In Taiwan there was a predominance of female patients with a 
female to male ratio of 2.2 to 1 [11]. Most studies have not shown the genders of affected 
individuals and OI worldwide usually occurs without gender differences [5, 6]. The difference in 
the gender ratio at birth of OI patients in Vietnam could be explained by insufficient diagnosis of 
OI cases, but could also be related to the slightly higher number of male births in Vietnam (male 
to female ratio of 112:100) [14].   
 In our study low birthweight (<2.5kg) [15] was identified in 39 OI patients. The mean 
birthweight was 2.7kg for boys and 2.6kg for girls with OI, which is significantly lower than for 
non-OI Vietnamese boys and girls (3.1kg and 3.0kg respectively) [16]. Decreased birth weight 
and short stature of OI sufferers are caused by abnormal intrauterine development of the foetus. 
The differences between the OI groups and controls appeared to be larger than might be expected 
from the overall smaller body frame in OI [17]. In a study by Sillence, similar data was presented 
and the majority of patients also had low birthweight [6]. 
117 patients (80.14%) were found to have blue sclera, including 41 patients with OI Type 
I, 34 patients with OI Type III and 42 patients with OI Type IV. The presence of blue sclera was 
slightly higher than in previous studies, especially for patients with Type IV. Other OI research 
studies have noted: a 75% incidence of blue sclera, including 89%, 80% and 58% for OI Types I, 
III and IV respectively [11]; a 78.1% (425/544) incidence of blue sclera [18]. 
In our research DI was identified in 89 patients (60.96%), including 21 OI Type I patients, 
34 OI Type III patients and 34 OI Type IV patients. Reported prevalence of DI in OI sufferers 
has been highly variable. In a study by Majorana, DI prevalence was shown to be 62.5% (10/16), 
with 30% of Type III patients affected [19].  Other authors have reported the prevalence of DI to 
be as low as 19% [20] and as high as 80% for OI Type III patients [11]. In our study, 26 patients 
(17.81%) were diagnosed with hearing loss of varying levels, however the incidence worldwide 
is variable, e.g. 6.7% [21] or 13.4% (73/544) of cases [18].  
Deformities appeared in all patients with differing severity and localization, and were 
most frequently observed in long bones. Spinal deformities and scoliosis were also common 
(Figure 4). Deformities in the lower limbs were found in 121 patients (82.88%), in upper limbs in 
80 patients (54.80%), in the spine in 91 patients (62.33%) and the chest in 74 patients (50.68%). 
Bowing and angulation deformities exist to varying degrees in OI sufferers, with frequent over-
modelling of the shafts of long bones [3]. In addition to long bone deformities occurring due to 
imperfect bone development or fracture healing problems, weight bearing alone can cause leg 
bowing [22]. In the Taiwan study, bone deformities were observed in 54% of patients [11]. 
Scoliosis, kyphosis, flattened vertebra and compression fractures are common in OI sufferers. 
Severe vertebral deformity may cause respiratory problems in some patients [22]. Previous 
studies reported scoliosis in 74.5% (76/102) [23] and 50% (157/316) of cases [24].  
The mean number of lifetime fractures for each OI patient in our study was 13.23. The 
mean number of lifetime fractures in Type I patients was 6.043, in Type III patients 20.76 and in 
Type IV patients 12.94. There were statistically signficant differences between the number of 
total fractures between the Type I and III groups (p=3.028×10-12), Type I and IV groups 
(p=2.81×10-6) and Type III and IV groups (p= 0.0001254) (Figure 1). Among those with Type III 
and Type IV OI, 18 patients (12.33%) had suffered more than 30 fractures each. We found 125 of 
the 146 patients (85.62%) suffered their first fracture in the first six years of life. Sillence also 
found that fractures usually first appear during the preschool period [6]. In both genders and for 
all OI Types fracture rates diminish during the teenage years, however the reason is not known 
[25]. 
Bisphosphonate therapy has been used in worldwide practice for OI treatment during 
three decades. In the beginning mostly pamidronate was used, there are also some studies about 
alendronate, but during last decade the most widely used medication is zoledronate [2, 
26,27,28,29].	  Bisphosphonate therapy has demonstrated good results by increase of the BMD 
and reduction of the fracture rate in the long and vertebral bones of the patients. In our research 
only 37 patients (10 type I, 12 type III, 15 type IV) were treated with bisphosphonates. Most of 
the OI Vietnamese patients could not follow bisphosphonate therapy due to inaccessability of 
adequate medical care, sustainment or counseling from the medical professionals.     
Totally surgery was performed in 163 times, including 100 osteosynthesis and 63 
osteotomy, with shows that in 2/3 cases surgery is performed due to fractures. The Fassier –
Duval telescopic rod is the best way to promote osteosynthesis and is broadly used in OI patients. 
Advantages of this new method is that implementation of telescope requires one proximal 
epiphyseal entry point to reach the distal eiphysis,	without requiring arthrotomy and with minimal 
damage of the growth plate. Following the patients, this method showed a reduction in secondary 
fractures and a long lasting osteosynthesis or osteotomy during growing bone [30,31].  Over an 
18 month period observation showed an average reoperation rate of 13% in OI patients treated by 
femoral and tibia Fassier-Duval telescopic IM [32]. Additional research showed Fassier-Duval 
telescopic rod was  most effectively applied in the case of multiple fractured long bone as well as 
severe deformities [33]. However in Vietnam conditions for the application of Fassier-Duval 
telescopic nails are absent. Intra-medular rod and sliding rod were currently the choice for many 
surgeons (55/58 patients), but implants are locally produced, also carry the sliding principle 
(figure 2) and have shown good clinical outcome. But the surgical activity for deformation 
correction was low, comparing to deformity rate in the lower limbs (82.88%), upper limbs 
(54.80%) or number of patients who needs assistance (39.73%). Correction of deformities will 
help improve quality of life in OI patients. 
Most of the patients in our study required assistance with ambulation: 58 (39.73%) moved 
independently; 22 (15.07%) were wheelchair-bound; 49 (33.56%) were only able to sit; 17 
(11.64%) were only able to lie down in bed. Lin et al. performed a retrospective study and 
documented the ability to walk without aids or devices in 100% of OI Type I, 63% of Type IV 
and 0% of Type III patients. Reliance on a wheelchair was reported in 100% of OI Type III and 
21% of OI Type IV sufferers in the same study [11].	 Wekre reported ambulation using a 
wheelchair in 20% (19/97) of patients of all OI types and 100% of patients with OI Type III [34]. 
 
	 	
Conclusion	
In this study we systematically detected OI patients in Vietnam, assessed their health, 
treatment and genealogical information. The number of affected individuals and amount of severe 
phenotypes found indicates that the disease is underdiagnosed in Vietnam, especially in cases 
where there is no family history and or mild cases. Our database is the foundation for improving 
OI investigation and treatment in Vietnam, and future phenotype-genotype studies. The results of 
this study will also be used to educate physicians and other medical professionals throughout the 
country on the signs and symptoms of OI in order to increase diagnosis and treatment levels and 
improve the quality of life of OI patients and their families. 
.  
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Figure 1. Association between OI Type and number of fractures  
Mean number of total fractures by OI Type:  
OI type  I = 6.043; OI type III = 20.76; OI type  IV = 12.94 
(p-value OI type I and OI  type III = 3.028e-12 ,     p-value OI type I and OI type IV = 2.81e-06 
 p-value OI type III and OI type IV= 0.0001254 ) 
		
Figure 2.  Osteotomy in OI patient with sliding rod method  
(a) Type III OI patient before operation; (b) X-ray of the patient before operation;  
(c) The patient 12 months after osteotomy; (d) X-ray 12 months after osteotomy. 
 
                     (a)                                                              (b)                                                                                               
 
                                 
                                   (c)                                          (d) 
  
		
Figure 3. Pedigree tree of the family with an OI history in two generations 
OI affected family members (circle – female; square – male) are highlighted in solid red. All 
family members marked with red colour (906, 911, 916, 917, 918) were subjected to genetic 
analysis and  included into the biobank.  
 
 
 
 
 
 
 
 
 
 
 
  
		
Figure 4. Typical patient with OI type III (severe deforming OI)  
(a) Type III OI patient aged 10 with short stature; (b) X-ray showing scoliosis; 
(c) X-ray showing lower limb deformities 
 
 
 
		
 
Table 1. Characteristics of 146 Vietnamese OI patients  
Characteristic Number of patients % 
Gender    
       Male  85 58.22 
       Female  61 41.78 
Age 
0-5 32 21.92% 
6-10 40 27.40% 
11-15 31 21.23% 
16-20 16 10.96% 
21-25 9 6.16% 
26-30 1 0.68% 
31-35 5 3.42% 
36-40 5 3.42% 
41-45 3 2.05% 
46-50 3 2.05% 
>50 1 0.68% 
Low  birthweight 
Male <2.5kg  21 14.38 
Female <2.5kg 18 12.33 
No information 7 4.79 
OI Type by Sillence 
I 46 31.51 
II 0 0.00 
III 46 31.51 
IV 54 36.98 
 
	
	  
		
Table 2. Frequency of signs and clinical symptoms of 146 Vietnamese OI patients 
 
 Total  number 
 of patients  
%  Number of patients according to 
OI type 
OI Type I 
 
OI Type 
III 
OI Type 
IV 
Blue sclera 
Yes 117 80.14% 41 34 42 
No 29 19.86% 5 12 12 
Hearing  
Hearing loss 26 17.81% 5 11 10 
Normal 120 82.19% 41 35 44 
Teeth      
DI 89 60.96% 21 34 34 
Normal 57 39.04% 25 12 20 
Mobility 
Lying 17 11.64% 0 14 3 
Sitting 49 33.56% 0 26 23 
Wheelchair bound 22 15.07% 3 6 13 
Normal  58 39.73% 43 0 15 
Deformity 
Upper limb 80 54.80% 11 43 26 
Lower limb 121 82.88% 27 45 49 
Spine (scoliosis, kyphosis) 91 62.33% 13 44 34 
Chest 74 50.68% 7 42 25 
         
	
		
Table 3. a)Fracture characteristics of 146 Vietnamese OI patients 
 Number of patients % 
Time of the first fracture  
Intrauterine 34 23.29% 
Perinatal 9 6.16% 
Before 6 years old 82 56.17% 
≥7 years old 14 9.59% 
No information and no fracture* 7 4.79% 
First fractured bone 
Upper arm 15 10.29% 
Forearm 9 6.16% 
Femur 92 63.01% 
Lower leg 14 9.59% 
Mixed (≥2 different bones) 9 6.16% 
No information and no fracture* 7 4.79% 
*There were 4 patients without any fractures, and 3 patients could not report the time of the first 
fracture and first fractured bone 
 
b) The types of fractures and the surgical treatment 
 Femur Lower leg Humerus Forearm Other Total 
Number of all fractures 764 
     
575 306 196 91 1932 
Number of patients with 
fractures 
132 102 87 72 41 142 
Number of surgeries 
- Osteosynthesis 
- Osteotomy 
115 
75 
40 
41 
18 
23 
1 
1 
0 
6 
6 
0 
0 
0 
0 
163 
100 
63 
 
 
 
 
 
 
 
 
 
		
Table 4. Characteristics of  133 mothers of 146 Vietnamese OI patients     
 Number of mothers % 
Miscarriage 
Yes 36 27.07% 
No 88 66.17% 
No information 9 6.76% 
Full term pregnancy 
Yes 111 76.03% 
No (≤37weeks) 21 14.38% 
No information 14 9.59% 
Mother’s age at OI patient’s birth 
≤35 years old 129 88.36% 
>35 years old 17 11.64% 
  
